s6y
Company name or ticker
Search
ADARx Pharmaceuticals, Inc.
4
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
Filed
Wednesday, September 30, 2026
Period
Sep 28, 2026
Accession number
0000947871-26-000910
Documents
ownership.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header